Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C Virus

被引:203
作者
Dowd, Kimberly A. [1 ]
Netski, Dale M. [1 ]
Wang, Xiao-Hong [3 ]
Cox, Andrea L. [1 ,2 ]
Ray, Stuart C. [1 ,2 ]
机构
[1] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA
[3] Third Mil Med Univ, Southwest Hosp, Chongqing, Peoples R China
关键词
CELLULAR IMMUNE-RESPONSES; SOURCE OUTBREAK; ACUTE-PHASE; PSEUDOPARTICLES; EPIDEMIOLOGY; TRANSMISSION; ENHANCEMENT; CHIMPANZEES; POPULATION; PROTEIN;
D O I
10.1053/j.gastro.2009.02.080
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Despite recent characterization of hepatitis C virus-specific neutralizing antibodies, it is not clear to what extent immune pressure from neutralizing antibodies drives viral sequence evolution in vivo. This lack of understanding is particularly evident in acute infection, the phase when elimination or persistence of viral replication is determined and during which the importance of the humoral immune response has been largely discounted. Methods: We analyzed envelope glycoprotein sequence evolution and neutralization of sequential autologous hepatitis C virus pseudoparticles in 8 individuals throughout acute infection. Results: Amino acid substitutions occurred throughout the envelope genes, primarily within the hypervariable region 1 of E2. When individualized pseudoparticles expressing sequential envelope sequences were used to measure neutralization by autologous sera, antibodies neutralizing earlier sequence variants were detected at earlier time points than antibodies neutralizing later variants, indicating clearance and evolution of viral variants in response to pressure from neutralizing antibodies. To demonstrate the effects of amino acid substitution on neutralization, site-directed mutagenesis of a pseudoparticle envelope sequence revealed amino acid substitutions in hypervariable region 1 that were responsible for a dramatic decrease in neutralization sensitivity over time. In addition, high-titer neutralizing antibodies peaked at the time of viral clearance in all spontaneous resolvers, whereas chronically evolving subjects displayed low-titer or absent neutralizing antibodies throughout early acute infection. Conclusions: These findings indicate that, during acute hepatitis C virus infection in vivo, virus-specific neutralizing antibodies drive sequence evolution and, in some individuals, play a role in determining the outcome of infection.
引用
收藏
页码:2377 / 2386
页数:10
相关论文
共 35 条
[1]   Epidemiology of hepatitis C virus infection [J].
Alter, Miriam J. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (17) :2436-2441
[2]   The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[3]   An interplay between hypervariable region 1 of the Hepatitis C Virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies [J].
Bartosch, B ;
Verney, G ;
Dreux, M ;
Donot, P ;
Morice, Y ;
Penin, F ;
Pawlotsky, JM ;
Lavillette, D ;
Cosset, FL .
JOURNAL OF VIROLOGY, 2005, 79 (13) :8217-8229
[4]   In vitro assay for neutralizing antibody to hepatitis C virus:: Evidence for broadly conserved neutralization epitopes [J].
Bartosch, B ;
Bukh, J ;
Meunier, JC ;
Granier, C ;
Engle, RE ;
Blackwelder, WC ;
Emerson, SU ;
Cosset, FL ;
Purcell, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14199-14204
[5]   Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes [J].
Bartosch, B ;
Dubuisson, J ;
Cosset, FL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (05) :633-642
[6]   Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain [J].
Bukh, Jens ;
Thimme, Robert ;
Meunier, Jean-Christophe ;
Faulk, Kristina ;
Spangenberg, Hans Christian ;
Chang, Kyong-Mi ;
Satterfield, William ;
Chisari, Francis V. ;
Purcell, Robert H. .
JOURNAL OF VIROLOGY, 2008, 82 (16) :8183-8195
[7]   Limited humoral immunity in hepatitis C virus infection [J].
Chen, M ;
Sällberg, M ;
Sönnerborg, A ;
Weiland, O ;
Mattsson, L ;
Jin, L ;
Birkett, A ;
Peterson, D ;
Milich, DR .
GASTROENTEROLOGY, 1999, 116 (01) :135-143
[8]   Cellular immune selection with hepatitis C virus persistence in humans [J].
Cox, AL ;
Mosbruger, T ;
Mao, Q ;
Liu, Z ;
Wang, XH ;
Yang, HC ;
Sidney, J ;
Sette, A ;
Pardoll, D ;
Thomas, DL ;
Ray, SC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (11) :1741-1752
[9]   Prospective evaluation of community-acquired acute-phase hepatitis C virus infection [J].
Cox, AL ;
Netski, DM ;
Mosbruger, T ;
Sherman, SG ;
Strathdee, S ;
Ompad, D ;
Vlahov, D ;
Chien, D ;
Shyamala, V ;
Ray, SC ;
Thomas, DL .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (07) :951-958
[10]   Comprehensive analyses of CD8+T cell responses during longitudinal study of acute human hepatitis C [J].
Cox, AL ;
Mosbruger, T ;
Lauer, GM ;
Pardoll, D ;
Thomas, DL ;
Ray, SC .
HEPATOLOGY, 2005, 42 (01) :104-112